Enfortumab vedotin-ejfv (solution), CAS [[1346452-25-2]]

Produktübersicht

• Artikelname: Enfortumab vedotin-ejfv (solution), CAS [[1346452-25-2]]
• Artikelnummer: MCE-HY-P99016B
• Hersteller Artikelnummer: HY-P99016B
• Alternativnummer: MCE-HY-P99016B-25MG,MCE-HY-P99016B-1MG,MCE-HY-P99016B-5MG,MCE-HY-P99016B-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

Enfortumab vedotin-ejfv (solution) is an anti-Nectin-4 antibody-drug conjugate (ADC). Enfortumab vedotin-ejfv (solution) is a fully humanized IgG1 antibody conjugated to the microtubule disrupting agent MMAE (HY-15162) via a protease-cleavable Val-Cit linker. The antibody portion is Enfortumab (HY-P99016), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Nectin-4 is an adhesion protein involved in cellular processes and tumorigenesis, and Enfortumab vedotin-ejfv (solution) is indicated for the inhibition of locally advanced or metastatic urothelial carcinoma[1][2].

Produkteigenschaften

• Molekulargewicht: 152000 (average)
• Reinheit: 99.78
• CAS Nummer: [1346452-25-2]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs),Nectin-4

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: ADC Related